Diabetic Macular Edema Market - Forecast(2024 - 2030)

Report Code: HCR 0244 Report Format: PDF + Excel
Diabetic Macular Edema (DME) is defined as an accumulation of fluid in the macula of the retina that controls the vision abilities of the human eye. DME is the disease that is followed by diabetic retinopathy. Diabetic retinopathy is a disease that severely damages the blood vessels of the retina, resulting in vision defects or vision loss. These blood vessels if left untreated begin to exert pressure in the eye and result in fluid leakage, causing DME.

The report “Global Diabetic Macular Edema Market” for the projected period 2016 to 2021 has been segmented on three different parameters. The global DME market has been primarily studied on the basis of different categories of Diabetic Macular Edema as per the Optical Coherence Tomography (OCT ) classification that are Spongiform DME, Cystoid Macular Edema and so on. The Diabetic Macular Edema market has also been studied on the basis of different treatment methods such as Anti-angiogenic drugs injection, Laser treatment and many more. The market has also been studied on the basis of different geographies and the level of population affected by the Diabetic Macular Edema disease in those geographies.

Diabetic Macular Edema Market

As per the study conducted by International Diabetes Federation (IDF), approximately 284 million people, almost equivalent to half of the European population are suffering from visually impairments out of which 39 million of them are totally blind. These kinds of diseases in addition to the human aspects also carry significant social as well as economic impact. Medical organizations and pharmaceuticals companies are investing substantially into R&D, infrastructure and technology to tackle the burden of these chronic diseases. DME only affects a certain percentage of diabetic patients; its percentage is likely to grow in the coming years. The number of people suffering from diabetes in Europe is speculated to rise from 55.2 million in 2010 to 66.2 million by 2030, DME cases would increase proportionately. There are several anti VEGF compounds which are being manufactured and currently into research phase. Asia-Pacific region is expected to be one of the emerging markets for DME treatment, as the diabetic population in the developing nations such as India, China and Indonesia are pacing up exponentially.

Sample Companies Profiled in this Report are:
  • Allergan PLC
  • Clearside Biomedical, Inc.
  • Novartis AG
  • Valeant Pharmaceuticals (Bausch & Lomb)
  • Regenron PLC
  • 10+

T0he Diabetic Macular Edema market report also comprises of the leading companies profiled in an extremely descriptive manner. The company profiles include financial summaries, strategies, recent developments and product portfolios of the leading companies in the Diabetic Macular Edema market. The report also incorporates a profound study of the market entropy, market forces and strategic analysis of the Diabetic Macular Edema market.
1. Diabetic Macular Edema Market - Overview
1.1. Definitions and Scope
2. Diabetic Macular Edema Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Diabetic Macular Edema Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Diabetic Macular Edema Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Diabetic Macular Edema Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Diabetic Macular Edema Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Diabetic Macular Edema Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Diabetic Macular Edema Market – By Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Spongiform
8.3.2. Diffuse Macular Edema
8.3.3. Cystoid Macular Edema
8.3.4. Serous Retinal Detachment
8.3.5. Tractional
8.3.6. Taut posterior hyaloid membrane (TPHM)
9. Diabetic Macular Edema Market – By Treatment Methods (Market Size -$Million / $Billion)
9.1. Laser Treatment
9.1.1. Focal Laser
9.1.2. Scatter Laser
9.1.3. Grid pattern photocoagulation
9.2. Anti-angiogenic Drugs Injection
9.2.1. Avastin
9.2.2. Lucentis
9.2.3. Eylea
9.3. Intravitreal Steriods
9.3.1. Kenalog
9.3.2. Ozurdex
9.3.3. lluvien
9.4. Anti–vascular Endothelial Growth Factor (VEGF) Therapy
9.5. Others
10. Diabetic Macular Edema - By Geography (Market Size -$Million / $Billion)
10.1. Diabetic Macular Edema Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Diabetic Macular Edema - South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Diabetic Macular Edema - Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Diabetic Macular Edema – APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
11. Diabetic Macular Edema Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Diabetic Macular Edema Market – Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practises for companies
13. Diabetic Macular Edema Market – Key Company List by Country Premium
14. Diabetic Macular Edema Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. Allergan PLC
14.3. Clearside Biomedical, Inc.
14.4. Novartis AG
14.5. Valeant Pharmaceuticals (Bausch & Lomb)
14.6. Regenron PLC
14.7. pSivida Corporation
14.8. Pfizer, Inc.
14.9. Bayer AG
14.10. Alimera Sciences, Inc.
14.11. Ariam Pharmaceuticals
14.12. Company 11
14.13. Company 12
14.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Diabetic Macular Edema Market -Appendix
15.1. Abbreviations
15.2. Sources
16. Diabetic Macular Edema Market -Methodology Premium
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
List of Tables:

Table1: Diabetic Macular Edema Market Overview 2021-2026
Table2: Diabetic Macular Edema Market Leader Analysis 2018-2019 (US$)
Table3: Diabetic Macular Edema Market Product Analysis 2018-2019 (US$)
Table4: Diabetic Macular Edema Market End User Analysis 2018-2019 (US$)
Table5: Diabetic Macular Edema Market Patent Analysis 2013-2018* (US$)
Table6: Diabetic Macular Edema Market Financial Analysis 2018-2019 (US$)
Table7: Diabetic Macular Edema Market Driver Analysis 2018-2019 (US$)
Table8: Diabetic Macular Edema Market Challenges Analysis 2018-2019 (US$)
Table9: Diabetic Macular Edema Market Constraint Analysis 2018-2019 (US$)
Table10: Diabetic Macular Edema Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table11: Diabetic Macular Edema Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table12: Diabetic Macular Edema Market Threat of Substitutes Analysis 2018-2019 (US$)
Table13: Diabetic Macular Edema Market Threat of New Entrants Analysis 2018-2019 (US$)
Table14: Diabetic Macular Edema Market Degree of Competition Analysis 2018-2019 (US$)
Table15: Diabetic Macular Edema Market Value Chain Analysis 2018-2019 (US$)
Table16: Diabetic Macular Edema Market Pricing Analysis 2021-2026 (US$)
Table17: Diabetic Macular Edema Market Opportunities Analysis 2021-2026 (US$)
Table18: Diabetic Macular Edema Market Product Life Cycle Analysis 2021-2026 (US$)
Table19: Diabetic Macular Edema Market Supplier Analysis 2018-2019 (US$)
Table20: Diabetic Macular Edema Market Distributor Analysis 2018-2019 (US$)
Table21: Diabetic Macular Edema Market Trend Analysis 2018-2019 (US$)
Table22: Diabetic Macular Edema Market Size 2018 (US$)
Table23: Diabetic Macular Edema Market Forecast Analysis 2021-2026 (US$)
Table24: Diabetic Macular Edema Market Sales Forecast Analysis 2021-2026 (Units)
Table25: Diabetic Macular Edema Market, Revenue & Volume, By Type, 2021-2026 ($)
Table26: Diabetic Macular Edema Market By Type, Revenue & Volume, By Spongiform, 2021-2026 ($)
Table27: Diabetic Macular Edema Market By Type, Revenue & Volume, By Diffuse Macular Edema, 2021-2026 ($)
Table28: Diabetic Macular Edema Market By Type, Revenue & Volume, By Cystoid Macular Edema, 2021-2026 ($)
Table29: Diabetic Macular Edema Market By Type, Revenue & Volume, By Serous Retinal Detachment, 2021-2026 ($)
Table30: Diabetic Macular Edema Market By Type, Revenue & Volume, By Tractional, 2021-2026 ($)
Table31: Diabetic Macular Edema Market, Revenue & Volume, By Treatment Methods, 2021-2026 ($)
Table32: Diabetic Macular Edema Market By Treatment Methods, Revenue & Volume, By Laser Treatment, 2021-2026 ($)
Table33: Diabetic Macular Edema Market By Treatment Methods, Revenue & Volume, By Anti-angiogenic Drugs Injection, 2021-2026 ($)
Table34: Diabetic Macular Edema Market By Treatment Methods, Revenue & Volume, By Intravitreal Steriods, 2021-2026 ($)
Table35: Diabetic Macular Edema Market By Treatment Methods, Revenue & Volume, By Anti–vascular Endothelial Growth Factor (VEGF) Therapy, 2021-2026 ($)
Table36: North America Diabetic Macular Edema Market, Revenue & Volume, By Type, 2021-2026 ($)
Table37: North America Diabetic Macular Edema Market, Revenue & Volume, By Treatment Methods, 2021-2026 ($)
Table38: South america Diabetic Macular Edema Market, Revenue & Volume, By Type, 2021-2026 ($)
Table39: South america Diabetic Macular Edema Market, Revenue & Volume, By Treatment Methods, 2021-2026 ($)
Table40: Europe Diabetic Macular Edema Market, Revenue & Volume, By Type, 2021-2026 ($)
Table41: Europe Diabetic Macular Edema Market, Revenue & Volume, By Treatment Methods, 2021-2026 ($)
Table42: APAC Diabetic Macular Edema Market, Revenue & Volume, By Type, 2021-2026 ($)
Table43: APAC Diabetic Macular Edema Market, Revenue & Volume, By Treatment Methods, 2021-2026 ($)
Table44: Middle East & Africa Diabetic Macular Edema Market, Revenue & Volume, By Type, 2021-2026 ($)
Table45: Middle East & Africa Diabetic Macular Edema Market, Revenue & Volume, By Treatment Methods, 2021-2026 ($)
Table46: Russia Diabetic Macular Edema Market, Revenue & Volume, By Type, 2021-2026 ($)
Table47: Russia Diabetic Macular Edema Market, Revenue & Volume, By Treatment Methods, 2021-2026 ($)
Table48: Israel Diabetic Macular Edema Market, Revenue & Volume, By Type, 2021-2026 ($)
Table49: Israel Diabetic Macular Edema Market, Revenue & Volume, By Treatment Methods, 2021-2026 ($)
Table50: Top Companies 2018 (US$)Diabetic Macular Edema Market, Revenue & Volume
Table51: Product Launch 2018-2019Diabetic Macular Edema Market, Revenue & Volume
Table52: Mergers & Acquistions 2018-2019Diabetic Macular Edema Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Diabetic Macular Edema Market 2021-2026
Figure 2: Market Share Analysis for Diabetic Macular Edema Market 2018 (US$)
Figure 3: Product Comparison in Diabetic Macular Edema Market 2018-2019 (US$)
Figure 4: End User Profile for Diabetic Macular Edema Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Diabetic Macular Edema Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Diabetic Macular Edema Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Diabetic Macular Edema Market 2018-2019
Figure 8: Ecosystem Analysis in Diabetic Macular Edema Market 2018
Figure 9: Average Selling Price in Diabetic Macular Edema Market 2021-2026
Figure 10: Top Opportunites in Diabetic Macular Edema Market 2018-2019
Figure 11: Market Life Cycle Analysis in Diabetic Macular Edema Market
Figure 12: GlobalBy TypeDiabetic Macular Edema Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy Treatment MethodsDiabetic Macular Edema Market Revenue, 2021-2026 ($)
Figure 14: Global Diabetic Macular Edema Market - By Geography
Figure 15: Global Diabetic Macular Edema Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 16: Global Diabetic Macular Edema Market CAGR, By Geography, 2021-2026 (%)
Figure 17: North America Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 18: US Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 31: Brazil Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 60: U.K Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 93: China Diabetic Macular Edema Market Value & Volume, 2021-2026
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Diabetic Macular Edema Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Diabetic Macular Edema Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 122: Russia Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Diabetic Macular Edema Market Value & Volume, 2021-2026 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Diabetic Macular Edema Market
Figure 131: Developments, 2018-2019*Diabetic Macular Edema Market
Figure 132: Company 1 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Diabetic Macular Edema Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Diabetic Macular Edema Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Diabetic Macular Edema Market Net Sales Share, By Geography, 2018 (%)